facebook twitter linkedin
rd offer

Download a conference poster

 
 
3rd AACR International Conference on Frontiers in Basic Cancer Research 2013, 18-22 September 2013, National Harbor, USA :
 
Repression of tumor survival pathways by novel, selective inhibitors of MNK1 and MNK2 kinases
 
 
 
24th EORTC-NCI-AACR Symposium, 6-9 November 2012, Dublin, Ireland:

"Novel PIM/FLT3 kinase inhibitors for cancer treatment"

"Development of Selective CDK8 Inhibitors for Colorectal Cancer Treatment"

American Association for Cancer Research Annual Meeting 2012, 31 March - 4 April 2012, Chicago, USA:

"Development of selective Pim kinase inhibitors for cancer treatment"


"Antitumor activity of SEL120: orally available dual inhibitors of CDK8/CDK9, for standalone and combination therapy in colon cancer"


3rd Cancer Targets & Therapeutics Conference, 27-28 February 2012, Las Vegas, USA:

"Development of Pim kinase inhibitors for cancer treatment"

"Antitumor activity of SEL120: An orally available dual inhibitors of Haspin/CDK9, for standalone and combination therapy with AuroraB inhibitors in solid tumors and hematopoietic malignancies"